Correlation Between Xvivo Perfusion and C Rad
Can any of the company-specific risk be diversified away by investing in both Xvivo Perfusion and C Rad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xvivo Perfusion and C Rad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xvivo Perfusion AB and C Rad AB, you can compare the effects of market volatilities on Xvivo Perfusion and C Rad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xvivo Perfusion with a short position of C Rad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xvivo Perfusion and C Rad.
Diversification Opportunities for Xvivo Perfusion and C Rad
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Xvivo and CRAD-B is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Xvivo Perfusion AB and C Rad AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C Rad AB and Xvivo Perfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xvivo Perfusion AB are associated (or correlated) with C Rad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C Rad AB has no effect on the direction of Xvivo Perfusion i.e., Xvivo Perfusion and C Rad go up and down completely randomly.
Pair Corralation between Xvivo Perfusion and C Rad
Assuming the 90 days trading horizon Xvivo Perfusion AB is expected to generate 2.05 times more return on investment than C Rad. However, Xvivo Perfusion is 2.05 times more volatile than C Rad AB. It trades about 0.17 of its potential returns per unit of risk. C Rad AB is currently generating about -0.4 per unit of risk. If you would invest 46,250 in Xvivo Perfusion AB on October 13, 2024 and sell it today you would earn a total of 2,750 from holding Xvivo Perfusion AB or generate 5.95% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Xvivo Perfusion AB vs. C Rad AB
Performance |
Timeline |
Xvivo Perfusion AB |
C Rad AB |
Xvivo Perfusion and C Rad Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Xvivo Perfusion and C Rad
The main advantage of trading using opposite Xvivo Perfusion and C Rad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xvivo Perfusion position performs unexpectedly, C Rad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C Rad will offset losses from the drop in C Rad's long position.Xvivo Perfusion vs. BioArctic AB | Xvivo Perfusion vs. Oncopeptides AB | Xvivo Perfusion vs. Hansa Biopharma AB | Xvivo Perfusion vs. Swedish Orphan Biovitrum |
C Rad vs. CellaVision AB | C Rad vs. Biotage AB | C Rad vs. Boule Diagnostics AB | C Rad vs. RaySearch Laboratories AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |